FDA Approves Merck’s KEYTRUDA for First-Line Treatment of Patients With Unresectable or Metastatic MSI-H or dMMR Colorectal Cancer Read more
VITRAC Therapeutics Initiated Global Clinical Development of VIC-1911, licensed from Taiho Pharmaceutical Read more
Biocare Medical and Bethyl Laboratories Announce Strategic Partnership for Antibody Development Read more
Nordic Nanovector’s Betalutin Receives Fast-track Designation from US FDA for Marginal Zone Lymphoma Read more
GSK receives first regulatory approval for Duvroq (daprodustat) in Japan for patients with anaemia due to chronic kidney disease Read more
Novartis announces MET inhibitor Tabrecta approved in Japan for advanced non-small cell lung cancer with METex14 Read more
Developing custom syringes for highly viscous formulations to be discussed at the Pre-filled Syringes San Francisco Conference Read more